Sin ce ancient tim es people have kn own a bo ut th e seasona l changes in mood and behavior (I ). The con cept of sea sonal mo od disorders da tes to th e dawn of medi cin e ( 1,2). Seasonal depressions were d escribed by Hippocr at es circa 400 BC (3). In t he sec ond ce nt u ry Greco-Roman ph ysicians were treating d epres sion a nd lethargy with su nligh t directed towards th e eyes (4,5). About 1500 yea rs ago Posid onius wrot e that " me la nc holy occurs in Autumn, wh ereas mania in Sum me r" (6). In 1894 Cook link ed seasonal loss of su nlig ht to a mood di sorder (7) . Cook described a syndrome cha racte rize d by loss of sexual desire, fatigu e, loss of energy a nd pro fou nd ly depressed mood. Seas on al cha nge s in mood we re also describ ed by Esq uiro l in 1845 (8) a nd by Kra ep elin in 192 I (9).
HI STORICAL ASPECTS
Sin ce ancient tim es people have kn own a bo ut th e seasona l changes in mood and behavior (I ). The con cept of sea sonal mo od disorders da tes to th e dawn of medi cin e ( 1,2). Seasonal depressions were d escribed by Hippocr at es circa 400 BC (3) . In t he sec ond ce nt u ry Greco-Roman ph ysicians were treating d epres sion a nd lethargy with su nligh t directed towards th e eyes (4, 5) . About 1500 yea rs ago Posid onius wrot e that " me la nc holy occurs in Autumn, wh ereas mania in Sum me r" (6) . In 1894 Cook link ed seasonal loss of su nlig ht to a mood di sorder (7) . Cook described a syndrome cha racte rize d by loss of sexual desire, fatigu e, loss of energy a nd pro fou nd ly depressed mood. Seas on al cha nge s in mood we re also describ ed by Esq uiro l in 1845 (8) a nd by Kra ep elin in 192 I (9) .
DIAG NO SIS
In 1984 Ros entha l and associates d escribed th e synd rome of "seasona l a ffective di sorder" (SAD ), a cond ition wh ere depressions in fall a nd wint er alte rna te with nondepressed periods in th e spring a nd su m me r ( 10) . Rosen th al a nd colleagu es sugges te d that in orde r to be diagn osed as havin g SAD a pati ent mu st meet th e following crite ria : a hist ory of maj or a ffec tive di sorder; a t least two consec u tive pr eviou s yea rs in whi ch th e dep ression s develop ed during fall or winter a nd remitt ed by th e following sp ring a nd su m me r; a bse nce of a ny ot he r Ax is I psychia tric d isord ers ; a nd absen ce of a ny clear-cut seasona lly chang ing psych osocial variab les that wou ld acc oun t for th e se aso na l variability in mood a nd beh avior ( 10) . Lat er, an op pos it e patt ern, d epressions in th e summer a nd non-depressed periods in th e win te r ("su rn-m er SAD " ), has been described ( I I). Thes e two typ es of SAD probably represent a subse t of a vari et y of seasona l behavioral dis orders. SAD has bee n includ ed in th e Revised Third Edition a nd in th e Fourth Edition of th e " Diagnostic and Sta tistica l Manual of M ental Disorders" of th e Am erican Psychiat ric Associat ion as "seasona l patt ern," a n adjectiva l modifi er of a ny form of seasonally rec urren t mood diso rd ers (12, 13) .
The onse t of wint er SAD occ urs usu all y between ag e 20 yea rs an d 30 yea rs, bu t a ffec te d peopl e oft en do not see k psychi atric help for some years (2, 14) . Many pati ents report di sliking wint e r since th eir teenage yea rs, t hou gh t he probl em usua lly becom es severe only in adu lthood. Sadn ess , a nxie ty, ir rit abil ity, decreased activity, diffi cu lti es at work, socia l withdrawal, cha nges in a ppe tite , decreased libido, a nd cha nge s in slee p are cha rac te ristic symptoms of wint er d ep ression (10) . Most win te r SAD patients hav e " a typical" d epressiv e symptoms suc h as inc reased sleep duration , increased appet it e a nd weight, a nd ca rbohyd ra te crav ing . Depressive episodes are gen erally mi ld to modera te but some patients need hospitali zation. Th e neurovegetativ e symptoms of " subsyndromal SAD " a re sim ilar to th ose of SAD but major d epression is ab sent (15) . Patients with wint er SAD may ex pe rie nce a reve rsal of th eir wint er symptoms in su m me r: mild hypomania, elevate d moo d, inc reased libido, socia l activity a nd e ne rgy, a nd d ecr ea sed sleep requ ir em ents, a ppe ti te and weigh t (2) . Most episodes of SAD occ ur within unipolar maj or depressive disorder, a substantial minority hav e accompanyin g hypom anic e pisodes (b ipo la r II di sord e r), and very few a re associat ed with manic e pisodes. Pati ents with summer d epression usua lly rep ort " typ ica l" vege tative sym pto ms , suc h as insomnia a nd loss of a pp eti te and weight ( I I) .
The d egree to whi ch seasonal cha nges a ffec t mood , e ne rgy, sleep, appetite, food preferen ce, or th e wish to soc ia lize with ot he r peopl e has be en ca lled "seaso na lity" ( 15) . Season ality ca n manifest to different degr ees in di ffere nt ind ividuals. Som e peopl e ex pe rie nce on ly very mild seasonal changes wh ile ot he rs are severely affect ed.
SAD in child re n usu all y pr esents with fa tigue , irrit a bilit y, d ifficu lty getting out of bed in th e morning a nd probl ems in schoo l ( 16) . Sa d ness a nd changes in a ppe tite have also been ob served in child re n with SAD. C hi ld re n wit h win te r SAD tend to blam e th e exte rnal world (pa re n ts, tea ch ers, etc .) for treating th em poorl y.
Identifica tion of a seasona l patt ern ca n only be mad e if both patient and ph ysician actively look for it (2, 17) . Clinicians sho uld as k: " W he n th e seasons change , do you I) Feel down or depressed? 2) Have less e ne rgy th an usu al? 3) Feel less productiv e or cre a tive? 4) Need more sleep ? 5) Have less con t ro l ove r you r appeti te?" If ph ysicians fail to ask th ese qu estions many patients with se asonal depression ma y be diagnosed as " non-seasona ls." EPIDEMIOLOGY Seasonality of mo od a nd beh avior is co m mo n throu gh out th e pop ulation ( 15, (17) (18) (19) . Su rveys suggest th at th e pr eval en ce of SAD in th e USA increases with incr easing latitud e and ranges from 1.4% in Florida to 9.7% in New H a m pshi re (18) . A survey in th e Washingt on area found th at a pproximate ly 4% of t he popul ation hav e wint er seasonal affective disorder and over 10% more hav e sub-syndrornal SAD ( 15) . Twenty-seven percent of responde n ts rep orted that changes with t he seasons were a problem for t hem, 66% reported sea son al cha nges in e ne rgy level, 64% re ported som e seasonal cha nges in mood, an d 49% reported seas on a l cha nge s in weight. Another survey, in New York Ci ty, ind icat ed approximat ely 6% with pot ential clinica l severity , 18% re porting mi lder symptoms that are bothersom e, a nd 35% noting symptoms but without com p la int (19) .
Many clinical st udies re port th at winter SAD ma inl y affec ts wom en (2, 14) . However, th e high pr op ortion of wome n see n in research clinics may result from se lect ion bias. Blaz er et al. suggest th at SAD wit h m ajor depressive episode s is mor e fre q ue n t a mo ng m en , wh ereas wom en more com mo nly ex perie nce minor depression wit h a seasonal patt ern (20) .
GENETICS
Th e st udy of th e ge ne tic basi s of SAD has recently rece ived a cons iderab le att ention (2 1). The data on th e ge ne t ics of seasona l affect ive di sorders a re of three types:
I. Famil iality: st udies on th e pr eval en ce of psychi a tric d isorde rs among relatives of pati ents with SAD sug ge ste d a fa m ilia l co n tribut ion to t he deve lopm ent of SAD (22-26); 2. H e rit ability: th e surveys of two coho rts of twins showed t hat ge netic sus ceptibi lit y to se ns itivity to se asonal change s runs in famili es (27,28); 3. Molecu la r gen et ic research: two ge ne tic variant s relat ed to se ro to nergic transmission, th e 5-HT f LPR and th e 5-HT2A, -1438G/A, ge ne promoter polym orphisms, are associ at ed with SAD ; th e for me r but not th e la tt er polym orphism is relat ed to seasonality (29-3 1).
Fut ure research m ay clarify th e role of diffe rent ge nes in t he d evelopm e n t of SAD. Th e purpose of molecul ar ge ne tic st ud ies on SAD inclu d es th e developm ent of predi cti ve testing for SAD th at ca n help to establish t he correct diagnosis a nd th e identification of target for th erap eutic drugs.
PATHOPHYSIOLOGY
Several lin es of evide nce sugges t th at di sturbed se ro to n in fun cti onin g plays a n important role in th e development of SAD. M any SAD sym pto ms such as overeating, ca r bo hyd rate craving , we igh t ga in, a nd ove rs lee ping ca n be relat ed to seroton ergic dysfun cti on. It has been sugges te d th at di e ta ry ca r bo hyd ra tes increase brain serotonin (32, 33) . Carbohyd ra te crav ing in patients with SAD may be a "s elf-m edi cation " procedure by whi ch brain seroto nin level is incr eased . In a post-morte m study wint er decr ease in serotonin co nce nt ra tions was observed in human hypothal a m us (34) . Se lec tive se ro ton in reuptake inhibitors have a ben efi cia l effec t in pa ti en ts with SAD (35, 36) . St udi es on th e effec t of ad m inis te ring of se ro to ne rgic ago nist rn-chlorophenyl-piperazin e in pati ents wit h SAD have shown t hat t he infusion of this subst an ce ca n act ivate patients a nd m ak e th em eupho ric (3 7-39) . Anot her serotonergic ag on ist, d-fe n flura rnine, has been foun d to be effective in rev ersing symptoms of SAD (40) . As not ed a bove, polym orphism in two seroto nin system gen es has been found to be associat ed wit h win te r SAD (2 1,29,30) .
Accord ing to th e "mela to nin hypothesis," SAD may be a result of a bno r mal se cretion of or sensitiv ity to m ela tonin , a nd pho toth e rapy may modify m elatoni n sec ret ion (2, I0) . Howeve r, oral ad m inist ration of m ela ton in to SAD patients who had respo nd ed to light th e rapy did not indu ce ret urn of th e depression, a nd a te no lol (t he beta-adren ergic receptor blocking drug which supp resses prod uction of melaton in) fail ed to induce remission in SAD (4 1). These observat ions raised qu esti on s as to whe t her mela to n in plays a n im po rta n t ro le in th e d evelop me nt of SAD and seaso na lity.
Th e " p hase-s hift" hypothesis sugges ts th at th e symp to ms of SAD may result from a bno r mally d elayed circadia n rh ythms (42) . Th is th eory is based on th e fact s th at bright light in th e eve ning del ays th e nocturnal rise of me latonin, a nd that bri ght light in t he morning adva nces th e melatoni n r hyt hm. T hr ee controlled clinical t rial s reported rece ntly support th e phase-shift hypothesis by d emonstrating th erap eutic su perior ity of ea rly mo rning ligh t exposu re over eve ning exposure or placeb o cont ro ls (43) (44) (45) . H owever, in two trials a minority of pa tie nts respond ed pr efe rentiall y to eve ning light (43, 44) .
De pu e a nd co lleagues pro posed that t he do pamine rg ic syst em mi ght be involved in t he pat hogen esis of SAD (46, 47) . It has been suggest ed th at a hypodop aminergic s ta te in the nigrostriata l syst em may be associated with up -r egu lation of dop amine receptors in th e pr efrontal corte x. Howeve r, a double-blind st udy showed t hat th e administrat ion of a combinat ion of levodopa plu s ca rbidopa was not supe rior to plac ebo in patie n ts with SAD (48) .
The st udy of th yroid funct ion in patien ts wit h SAD is of cons ide ra ble int e rest, beca use sym p toms of SAD incl ude d ecr eased e nergy a nd weight gain (2,10), wh ich are also com mo n in hypothyroid ism (49) . It is possibl e t ha t pe rsons with SAD have a subtle decr ease in th yroid fun cti on sim ila r to th at which has been descri bed in some pati ents with non -season al depression (50,5 1 (55) , a nd Lingjae rd e et al. (56) . We st ud ied blood levels of free th yroxin e (T4) a nd th yroid-sti mulati ng hormon e (TS H ) in SAD pati ents a nd m at ch ed con t ro ls in th e win ter (54) . We foun d th at free T4 blood levels we re slight ly but significa ntly lower in pat ien ts th an in heal th y volu nt eers but th ere was no diff eren ce in T SH levels bet wee n patie n ts a nd norma l volun teers. Fu ture research will be need ed to d et ermine whet her th e di fferen ce in th yroid fun cti on betwee n SAD pa ti ents a nd controls is a n epiphe nome non or is related to th e biological m ech anisms t hat ca use sym ptoms of SAD .
Man y SAD patients seek profession al treatm en t for d ep ressio n but th ey are not diagnos ed as having SAD. This m ay be related to th e ph ysicia n's insuffi cient knowl edge about SAD a nd seasonality and/or th e ph ysician 's inability to gather th e a ppropria te history because of th e pati ent 's un coop erative ness or the ph ysician's failure to cond uc t th e appropriate di a gn ostic int ervi ew. Treat me nt s generall y effective for depressi on including com bine d psych otherapy a nd a n tid epressant medi cation s ofte n do not work un til spring time .
Light is th e m ainst ay of t reatm e n t for win ter depression (2,10 , 14,17 ,57) . The efficacy of light treat m ent has bee n show n in many co ntroll ed studies in diffe rent cou nt ries. Light th erapy ca uses improvem ent in mos t SAD patie nt s. For exa m ple, Oren a nd Rosenthal rep ort ed th at significa n t improve m e nt in depressive symptoms occurre d in at least three-qu art ers of SAD pati ents treat ed wit h lig ht (2) . Many research ers reported th at morning is th e mo st effec t ive ti m e for ligh t th erapy (2, (43) (44) (45) wh ereas oth ers have found pati ents to resp ond we ll to light at oth er tim es of th e day (58-6 1) . Treatm ent wit h 10,000 lux fo r 30 minut es in th e morning appears to be as successful as 2500 lux for 120 minut es (62) . Lat ely, t he highe r levels of light inte ns ity have been pr eferred beca use th ey allow for sho rter daily treatments. Light t re at me n t is easy to ad m iniste r in ou t pa tient se ttings, lacks major sid e effec ts, a nd is cos t-effective. Cau tion is recomm e nd ed whe n light th e rapy is us ed in patients with a tendency toward m ania or wit h ph otosensi tive skin.
Patients initi all y sho uld be give n mo rn ing light sho r t ly aft er awakening a t th e do se of 10,000 lux for 30 minut es ( 14,5 7) . If this treatme nt fai ls to elicit an a nt ide pressa n t response within several days th e treatm ent ti m e sho uld be exte nde d a nd/or eve ning treatm ent shou ld be added . O ren a nd Rosen th al sugges te d that mo st SAD patients require a t least 45 minut es a day of light t herapy at th e 10,000 lux illuminance (2) .
Sertraline a nd flu oxe tine a ppeared to be effect ive in SAD but less effec t ive than ligh t t he ra py (57, 63) . For exam ple, Ruh r m a nn et a l. rec ent ly conduct ed a study th at di rectl y co m pa re d br ight light a nd flu oxeti ne in the treatment of SAD (63) . The remission effec t for light was supe rior to Ilu oxe t ine (50 % vs. 25%), and lig h t th erapy improved H amilton Depression Ra ting Scale scores fast e r t han t he adm inistration of flu oxe tine. Se ro to nin-agonis t d-fenfluramin e is effective in t rea t m e n t of overweight pati ents with SAD (40) . Antid epressive drugs a rc ofte n co m bined wi t h light th erapy. Lithium, va lp ro ic ac id, ca rba maze pine, and ga ba pe nti n ca n be used to con tro l th e hypom anic sym ptoms th at affect so me SAD pati e nt s in spring an d sum me r (17) .
Light t reatmen t a nd me d ica tio ns ca nnot so lve a ll psychologica l problem s in all cases of SAD . Psych oth e rapy inclu d ing cognitive, be havioral , and insi ght-ori ent ed th erapy may be useful for some SAD patients ( 14, 17) .
A rece nt con trolled stu dy suggested t hat high-de nsity negative ai r ioni za tio n may ac t as a n a nt ide pressant in pa ti e nt s wi th SAD (43). Subj ect s were random ly assigne d to a 3-4 wee k t reat me nt period with 30 mi nute negative ion expos ure sessio ns every day, a t low and hi gh ion co nce nt ra t ion . The reduction in depression rating scale scores was significa nt ly greate r at the high e r dose th a n at t he lowe r dos e. Th e resu lts of this study support previous reports th at exposure to negative ions may have a mood -enhancing effec t (64) (65) (66) .
Di et a nd exe rc ise are important co nside ra tions in SAD a nd should be part of th e SAD patient's health maint en ance plan ( 14, 17) . Possibl y, St. John's wort has a n antidepres sive effec t on pat ients with SAD ( 17).
C ONCLUS IO N Sea son al changes in mood , e ne rgy, slee p, a ppe tite, food preference, or th e wish to socia lize with other people a re com mon in the ge neral popu la tion. In th e past 15 yea rs scie ntists have establishe d a firm definition of th e win ter SAD an d seasonality, a nd t he efficacy of light th erapy for wint er SAD . In th e past sev eral years resea rche rs have found that ge ne tic fact ors play a n important ro le in th e e tiology of SAD and seasonality. We ca n expect that our knowl ed ge a bou t t he et iology a nd pathogen esi s of SAD and seasonalit y will grow in th e yea rs to co me.
